Put companies on watchlist
European Healthcare Acquisition & Growth Company B.V.
ISIN: NL0015000K10
WKN: A3C60V
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

EN GIF 300X250

European Healthcare Acquisition & Growth Company B.V. · ISIN: NL0015000K10 · EQS - Company News (44 News)
Country: Germany · Primary market: Netherlands · EQS NID: 1251470
23 November 2021 04:10PM

European Healthcare Acquisition & Growth Company B.V. - Home Member State Notification


DGAP-News: European Healthcare Acquisition & Growth Company B.V. / Key word(s): Miscellaneous
European Healthcare Acquisition & Growth Company B.V. - Home Member State Notification

23.11.2021 / 16:10
The issuer is solely responsible for the content of this announcement.


European Healthcare Acquisition & Growth Company B.V. - Home Member State Notification

Article 5:25a of the Dutch Financial Supervision Act (Wet op het financieel toezicht) requires all listed companies to publicly announce which country is their "home member state" for the purposes of regulation of their disclosure obligations under Directive 2004/109/EG of the European Parliament and of the Council of 15 December 2004 on the harmonisation of transparency requirements in relation to information about issuers whose securities are admitted to trading on a regulated market and amending Directive 2001/34/EC (the EU Transparency Directive).

European Healthcare Acquisition & Growth Company B.V. hereby announces that its home member state is the Netherlands. This disclosure is also available on www.ehc-company.com.

European Healthcare Acquisition & Growth Company B.V.

General Enquiries
+49 (0) 89 4523240
info@ehc-company.com

Media Enquiries
Finsbury Glover Hering
Kai Peter Rath
Berliner Allee 44
40212 Düsseldorf
Germany

+49 211 43079-209
kai.rath@fgh.com



23.11.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: European Healthcare Acquisition & Growth Company B.V.
c/o ALR Treuhand GmbH; Theresienhöhe 28
80339 München
Germany
ISIN: NL0015000K10, NL00115000K28
WKN: A3C60V
Listed: Foreign Exchange(s) Amsterdam
EQS News ID: 1251470

 
End of News DGAP News Service

1251470  23.11.2021 

fncls.ssp?fn=show_t_gif&application_id=1251470&application_name=news&site_id=boersengefluester_html
Visual performance / price development - European Healthcare Acquisition & Growth Company B.V.
Smart analysis and research tools can be found here.

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2024
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.